Ann-Na Cho

Dr. Ann-Na Cho

Macquarie University, Sydney, New South Wales, Australia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAnn-Na Cho
Ann-Na Cho
YJYoonhee Jin
Yoonhee Jin
YAYeonjoo An
Yeonjoo An
JKJin Kim
Jin Kim
YCYi Sun Choi
Yi Sun Choi
SCSeung-Woo Cho
Seung-Woo Cho
Brain organoids derived from human pluripotent stem cells provide a highly valuable in vitro model to recapitulate human brain development and neurological diseases. However, the current systems for brain organoid culture require further improvement for the reliable production of high-quality organoids. Here, we demonstrate two engineering elements to improve human brain organoid culture, (1) a human brain extracellular matrix to provide brain-specific cues and (2) a microfluidic device with periodic flow to improve the survival and reduce the variability of organoids. A three-dimensional culture modified with brain extracellular matrix significantly enhanced neurogenesis in developing brain organoids from human induced pluripotent stem cells. Cortical layer development, volumetric augmentation, and electrophysiological function of human brain organoids were further improved in a reproducible manner by dynamic culture in microfluidic chamber devices. Our engineering concept of reconstituting brain-mimetic microenvironments facilitates the development of a reliable culture platform for brain organoids, enabling effective modeling and drug development for human brain diseases.

26 September 2017 in Biomacromolecules
Verified
Journal Article
Closed access
JSJisoo Shin
Jisoo Shin
ECEun Jung Choi
Eun Jung Choi
JCJung Ho Cho
Jung Ho Cho
ACAnn-Na Cho
Ann-Na Cho
YJYoonhee Jin
Yoonhee Jin
SCSeung-Woo Cho
Seung-Woo Cho

11 July 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
YJYoonhee Jin
Yoonhee Jin
JLJung Seung Lee
Jung Seung Lee
JKJin Kim
Jin Kim
SMSungjin Min
Sungjin Min
SWSoohyun Wi
Soohyun Wi
SCSeung-Woo Cho
Seung-Woo Cho

1 December 2014 in Biomaterials
Verified
Journal Article
Closed access
HPHyun-Ji Park
Hyun-Ji Park
SYSeung Jung Yu
Seung Jung Yu
KYKisuk Yang
Kisuk Yang
YJYoonhee Jin
Yoonhee Jin
ACAnn-Na Cho
Ann-Na Cho
SCSeung-Woo Cho
Seung-Woo Cho

9 June 2023 in Science Advances
Verified
Journal Article
Open access
RMRamón Martínez-Mármol
Ramón Martínez-Mármol
RGRosina Giordano-Santini
Rosina Giordano-Santini
EKEva Kaulich
Eva Kaulich
ACAnn-Na Cho
Ann-Na Cho
MPMagdalena Przybyla
Magdalena Przybyla
MHMassimo A. Hilliard
Massimo A. Hilliard
Numerous viruses use specialized surface molecules called fusogens to enter host cells. Many of these viruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can infect the brain and are associated with severe neurological symptoms through poorly understood mechanisms. We show that SARS-CoV-2 infection induces fusion between neurons and between neurons and glia in mouse and human brain organoids. We reveal that this is caused by the viral fusogen, as it is fully mimicked by the expression of the SARS-CoV-2 spike (S) protein or the unrelated fusogen p15 from the baboon orthoreovirus. We demonstrate that neuronal fusion is a progressive event, leads to the formation of multicellular syncytia, and causes the spread of large molecules and organelles. Last, using Ca 2+ imaging, we show that fusion severely compromises neuronal activity. These results provide mechanistic insights into how SARS-CoV-2 and other viruses affect the nervous system, alter its function, and cause neuropathology.

1 January 2018 in Biomaterials
Verified
Journal Article
Closed access
JLJung Seung Lee
Jung Seung Lee
ACAnn-Na Cho
Ann-Na Cho
YJYoonhee Jin
Yoonhee Jin
JKJin Kim
Jin Kim
SKSuran Kim
Suran Kim
SCSeung-Woo Cho
Seung-Woo Cho